Frontiers | Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies | Immunology
VEGF Inhibition and Renal Thrombotic Microangiopathy | NEJM
Systemic autoimmune disorders associated with thrombotic microangiopathy: A cross-sectional analysis from the French National TMA registry: Systemic autoimmune disease-associated TMA - European Journal of Internal Medicine
References in Emerging Concepts in Hematopoietic Stem Cell Transplantation–Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments - American Journal of Kidney Diseases
Thrombotic Microangiopathy can result from different molecular... | Download Scientific Diagram
IJMS | Free Full-Text | Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms | HTML
Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury | Nature Reviews Nephrology
PDF) Thrombotic microangiopathies assessment: mind the complement
Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics | Nature Reviews Nephrology
Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers | Haematologica
Unfolding the pathophysiology of congenital thrombotic thrombocytopenic purpura in pregnancy: lessons from a cluster of familial cases - American Journal of Obstetrics & Gynecology
A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. - Abstract - Europe PMC
References in Emerging Concepts in Hematopoietic Stem Cell Transplantation–Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments - American Journal of Kidney Diseases
Endothelial cell functions impaired by interferon in vitro: Insights into the molecular mechanism of thrombotic microangiopathy associated with interferon therapy - Thrombosis Research
Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers | Haematologica
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time? - Cancer Treatment Reviews
Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics - Saha - 2017 - Journal of Thrombosis and Haemostasis - Wiley Online Library
JCM | Free Full-Text | Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management | HTML
A Fatal Case of Thrombotic Microangiopathy Without Schistocytosis and Absent Biochemical Markers of Hemolysis - The American Journal of the Medical Sciences
Serum Neutrophil Extracellular Trap Levels Predict Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation - Biology of Blood and Marrow Transplantation
Serum Neutrophil Extracellular Trap Levels Predict Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation - Biology of Blood and Marrow Transplantation
Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic Purpura* - Journal of Biological Chemistry
IJMS | Free Full-Text | Increase of Neutrophil Activation Markers in Venous Thrombosis—Contribution of Circulating Activated Protein C | HTML
Thrombotic Microangiopathy in Inverted Formin 2–Mediated Renal Disease | American Society of Nephrology
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium | Nature Reviews Cardiology
